None listed
Conditions
Brief summary
Observation study, 1 years We observation of concentration of voriconazole by patients with aspergillus infection. They observation only through concentration of voriconazole 12 month after first dose of voriconazole. Concentrations of voriconazole will be evaluated. We will evaluated variability of concentrations (inter and intraindividual variability)
Interventions
this study will only review patients who have already been prescribed voriconazole to treat their infection.
the dose of voriconazole administered, 200 mg twice daily; the mode of administration, oral tablet.
the duration of administration, 12 months; All participants who have received voriconazole will be included in the study, and will be observed for up to 12 months after commencing voriconazole.
only data from medical records will be collected for the study: renal function and liver functi
this study will only review patients who have already been prescribed voriconazole to treat their infection. the dose of voriconazole administered, 200 mg twice daily; the mode of administration, oral tablet. the duration of administration, 12 months; All participants who have received voriconazole will be included in the study, and will be observed for up to 12 months after commencing voriconazole. only data from medical records will be collected for the study: renal function and liver function (drug induced kidney or liver dysfunction) blood voriconazole concentrations from medical records only The records of all patients admitted to University Hospital Motol between 1/01/2020 and 30/06/2022 will be reviewed,
Sponsors
University Hospital Motol
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
adult patients, patients treatment with voriconazole, agreement with study
Exclusion criteria
none
Outcome results
None listed